Younis Baqi
Affiliations: | 2007-2008 | Chemistry | Harvard University, Cambridge, MA, United States |
Google:
"Younis Baqi"Mean distance: 7.31 | S | N | B | C | P |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Baqi Y, Rashed M, Schäkel L, et al. (2020) Development of Anthraquinone Derivatives as Ectonucleoside Triphosphate Diphosphohydrolase (NTPDase) Inhibitors With Selectivity for NTPDase2 and NTPDase3. Frontiers in Pharmacology. 11: 1282 |
Li W, Guillaume J, Baqi Y, et al. (2020) Synthesis and structure-activity relationships of cerebroside analogues as substrates of cerebroside sulphotransferase and discovery of a competitive inhibitor. Journal of Enzyme Inhibition and Medicinal Chemistry. 35: 1503-1512 |
Tian M, Abdelrahman A, Baqi Y, et al. (2020) Discovery and structure-relationships of salicylanilide derivatives as potent, non-acidic P2X1 receptor antagonists. Journal of Medicinal Chemistry |
Müller CE, Baqi Y, Namasivayam V. (2020) Agonists and Antagonists for Purinergic Receptors. Methods in Molecular Biology (Clifton, N.J.). 2041: 45-64 |
Attah IY, Neumann A, Al-Hroub H, et al. (2019) Ligand binding and activation of UTP-activated G protein-coupled P2Y and P2Y receptors elucidated by mutagenesis, pharmacological and computational studies. Biochimica Et Biophysica Acta. General Subjects. 129501 |
Mouro FM, Köfalvi A, André LA, et al. (2019) Memory deficits induced by chronic cannabinoid exposure are prevented by adenosine AR receptor antagonism. Neuropharmacology. 155: 10-21 |
Jiang J, Seel C, Temirak A, et al. (2019) A2B Adenosine Receptor Antagonists with Picomolar Potency. Journal of Medicinal Chemistry |
Armida M, Matteucci A, Pèzzola A, et al. (2019) Modulating P1 Adenosine Receptors in Disease Progression of SOD1 Mutant Mice. Neurochemical Research |
Baqi Y, Müller CE. (2018) Antithrombotic P2Y receptor antagonists: recent developments in drug discovery. Drug Discovery Today |
Faivre E, Coelho JE, Zornbach K, et al. (2018) Beneficial Effect of a Selective Adenosine A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease. Frontiers in Molecular Neuroscience. 11: 235 |